These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13650489)

  • 21. Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants.
    Voepel N; Boes A; Edgue G; Beiss V; Kapelski S; Reimann A; Schillberg S; Pradel G; Fendel R; Scheuermayer M; Spiegel H; Fischer R
    Biotechnol J; 2014 Nov; 9(11):1435-45. PubMed ID: 25200253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.
    Walk J; Reuling IJ; Behet MC; Meerstein-Kessel L; Graumans W; van Gemert GJ; Siebelink-Stoter R; van de Vegte-Bolmer M; Janssen T; Teelen K; de Wilt JHW; de Mast Q; van der Ven AJ; Diez Benavente E; Campino S; Clark TG; Huynen MA; Hermsen CC; Bijker EM; Scholzen A; Sauerwein RW
    BMC Med; 2017 Sep; 15(1):168. PubMed ID: 28903777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi.
    Beier JC; Davis JR; Vaughan JA; Noden BH; Beier MS
    Am J Trop Med Hyg; 1991 May; 44(5):564-70. PubMed ID: 2063960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity.
    Mitchell RA; Altszuler R; Frevert U; Nardin EH
    Sci Rep; 2016 Sep; 6():32575. PubMed ID: 27624667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.
    Kublin JG; Mikolajczak SA; Sack BK; Fishbaugher ME; Seilie A; Shelton L; VonGoedert T; Firat M; Magee S; Fritzen E; Betz W; Kain HS; Dankwa DA; Steel RW; Vaughan AM; Noah Sather D; Murphy SC; Kappe SH
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectivity of
    McCall MBB; Wammes LJ; Langenberg MCC; van Gemert GJ; Walk J; Hermsen CC; Graumans W; Koelewijn R; Franetich JF; Chishimba S; Gerdsen M; Lorthiois A; van de Vegte M; Mazier D; Bijker EM; van Hellemond JJ; van Genderen PJJ; Sauerwein RW
    Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.
    Nardin EH; Nussenzweig V; Nussenzweig RS; Collins WE; Harinasuta KT; Tapchaisri P; Chomcharn Y
    J Exp Med; 1982 Jul; 156(1):20-30. PubMed ID: 7045272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporozoite Route of Infection Influences In Vitro var Gene Transcription of Plasmodium falciparum Parasites From Controlled Human Infections.
    Dimonte S; Bruske EI; Hass J; Supan C; Salazar CL; Held J; Tschan S; Esen M; Flötenmeyer M; Koch I; Berger J; Bachmann A; Sim BK; Hoffman SL; Kremsner PG; Mordmüller B; Frank M
    J Infect Dis; 2016 Sep; 214(6):884-94. PubMed ID: 27279526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium liver load following parenteral sporozoite administration in rodents.
    Ploemen IH; Chakravarty S; van Gemert GJ; Annoura T; Khan SM; Janse CJ; Hermsen CC; Hoffman SL; Sauerwein RW
    Vaccine; 2013 Jul; 31(34):3410-6. PubMed ID: 23063834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.
    Silvie O; Greco C; Franetich JF; Dubart-Kupperschmitt A; Hannoun L; van Gemert GJ; Sauerwein RW; Levy S; Boucheix C; Rubinstein E; Mazier D
    Cell Microbiol; 2006 Jul; 8(7):1134-46. PubMed ID: 16819966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing longevity of Plasmodium vivax and P. falciparum sporozoites after dissection from mosquito salivary glands.
    Lupton EJ; Roth A; Patrapuvich R; Maher SP; Singh N; Sattabongkot J; Adams JH
    Parasitol Int; 2015 Apr; 64(2):211-8. PubMed ID: 25481362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of naturally occurring
    Gomes FM; Hixson BL; Tyner MDW; Ramirez JL; Canepa GE; Alves E Silva TL; Molina-Cruz A; Keita M; Kane F; Traoré B; Sogoba N; Barillas-Mury C
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12566-12571. PubMed ID: 29114059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Plasmodium sporozoite survives RTS,S vaccination.
    Snounou G; Grüner AC; Müller-Graf CD; Mazier D; Rénia L
    Trends Parasitol; 2005 Oct; 21(10):456-61. PubMed ID: 16109504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
    van Schaijk BC; Janse CJ; van Gemert GJ; van Dijk MR; Gego A; Franetich JF; van de Vegte-Bolmer M; Yalaoui S; Silvie O; Hoffman SL; Waters AP; Mazier D; Sauerwein RW; Khan SM
    PLoS One; 2008; 3(10):e3549. PubMed ID: 18958160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
    Chappel JA; Hollingdale MR; Kang AS
    Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity in the acquisition of naturally acquired antibodies to cell-traversal protein for ookinetes and sporozoites (CelTOS) and thrombospondin-related adhesion protein (TRAP) of Plasmodium falciparum in naturally infected patients from unstable malaria areas in Iran.
    Pirahmadi S; Zakeri S; Mehrizi AA; Karimi L; Djadid ND
    Acta Trop; 2019 Feb; 190():365-374. PubMed ID: 30543766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM; Oliveira GA; Nardin EH
    J Immunol; 2005 Dec; 175(11):7575-85. PubMed ID: 16301667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.
    Hoffman SL; Billingsley PF; James E; Richman A; Loyevsky M; Li T; Chakravarty S; Gunasekera A; Chattopadhyay R; Li M; Stafford R; Ahumada A; Epstein JE; Sedegah M; Reyes S; Richie TL; Lyke KE; Edelman R; Laurens MB; Plowe CV; Sim BK
    Hum Vaccin; 2010 Jan; 6(1):97-106. PubMed ID: 19946222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.